HAI Book 2025 - Flipbook - Page 51
Onset Alzheimer9s Disease Study (LEADS): A
multi-method approach
The association between amyloid and physical
activity in a racially diverse cohort of older adults
Whole blood gene expression is associated with
plasma p-tau217 levels via amyloid-PET and sex
Plasma A´ as predictor of A´ accumulation in
non-demented participants
The relative prevalence of tau severity stages is
related to amyloid burden, clinical diagnosis and
age
Head-to-head trajectories of tau PET and
plasma p-tau217 as a function of A´
Functional submodules in the human locus
coeruleus are differentially susceptible to tau
pathology
Sex-specific associations of BMI, amyloid, and
regional tau deposition in community-dwelling
cognitively normal older adults
Assessment of ATN with a single dynamic [18]FPI-2620 recording
Tau-PET detects advanced primary age-related
tauopathy mimicking early-stage AD
Amyloid status moderates associations between
hippocampal microstructure, PET tau burden,
and memory in dementia-free older adults
Performance of an MR-independent analysis
pipeline for quantification of tau abnormality
using [18F]flortaucipir PET
Functional and structural connectivity patterns
predict longitudinal tau spreading in
asymptomatic individuals expressing A´
pathology
Plasma phospho-tau 217, neurofilament-light,
and glial fibrillary acidic protein are differentially
associated with longitudinal neuropsychiatric
symptoms across the early cognitive spectrum
An assessment of the utility of flortaucipir PET
to detect four-repeat tau pathology in a globular
glia tauopathy case-series
Molecular imaging of neurodegeneration 3
mitochondria, associated proteins and synapses
(MIND-MAPS) in frontotemporal dementia
Evaluating tVNS effects on cognitive outcomes
and modulating factors in asymptomatic older
adults: study design of the WALLe Trial
Cerebral perfusion indices from early-phase
[18F]-MK6240 dynamic Tau PET imaging in brain
regions associated with Alzheimer9s Disease
progression in an aging population.
HAI2025 - 51
Francisco, San Francisco, San Francisco, CA,
US
Yiwen Dong, Department of Biostatistics and
Health Data Science, School of Public Health,
Pittsburgh, PA, US
Yiwen Dong, Department of Biostatistics and
Health Data Science, School of Public Health,
Pittsburgh, PA, US
Alexandra Gogola, Department of Radiology,
University of Pittsburgh School of Medicine,
Pittsburgh, PA, US
Karly Cody, Department of Neurology and
Neurological Sciences, Stanford University,
Stanford, CA, US
Bruna Bellaver, University of Pittsburgh,
Department of Psychiatry, PA, United States of
America, Pittsburgh, PA, US
Timothy Lawn, Athinoula A. Martinos Center
for Biomedical Imaging, Department of
Radiology, Massachusetts General Hospital
and Harvard Medical School, 02129, Boston,
MA, USA, Boston, MA, US
Joshua Gills, New York University Grossman
School of Medicine, New York City, NY, US
Johannes Gnörich, Department of Nuclear
Medicine, University Hospital, LMU Munich,
Munich, DE
Michel Grothe, Reina Sofia Alzheimer Center,
CIEN Foundation, ISCIII, Madrid, ES
Daniel Callow, Johns Hopkins School of
Medicine Department of Psychiatry and
Behavioral Sciences, Baltimore, MD, US
Alexander DelBene, Department of Radiology,
University of Pittsburgh School of Medicine,
Pittsburgh, PA, US
Jonathan Gallego-Rudolf, Douglas Research
Centre, Montreal, QC, CA
Jennifer Gatchel, Massachusetts General
Hospital, Department of Psychiatry, Boston,
MA, US
Rodolfo Gatto, Department of Neurology, Mayo
Clinic, Rochester, MN, US
Mica Clarke, Perceptive, London, GB
Nina Engels-Domínguez, The Athinoula A.
Martinos Center for Biomedical Imaging,
Department of Radiology, Massachusetts
General Hospital, Harvard Medical School,
Boston, MA, US
Maeva Dhaynaut, Yale PET Center,
Department of Radiology & Biomedical
Imaging, Yale University School of Medicine,
New Haven, CT, US
